Ranolazine-d8 H-PEG4-CH2COOH Bethesda (MD): National Center for

Bethesda (MD): National Center for Biotechnology Information (US)

and SUN concentrations and renal caspase 3/7 activity decreased in 5/6Nx mice treated with NS-03-08

and apoptotic ratio compared with those in the IR+Mel group

Activator of epithelial KCa channels

Formula: C16H14N4O3S

Ranolazine-d8 H-PEG4-CH2COOH Bethesda (MD): National Center forRanolazine d8 (CVT 303 d8) is the deuterium labeled Ranolazine. Ranolazine (CVT 303) is an anti angina drug that achieves its effects by inhibiting the late phase of inward sodium current (INa and IKr with IC50 values of 6 M and 12 M, respectively) without affecting heart rate or blood pressure (BP). Ranolazine is also a partial fatty acid oxidation (FAO) inhibitor. Antianginal agent. Product information CAS Number: 1092804 88 0 Molecular Weight: 435.